Gynesonics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.5Mgeneral payments (2019-2025)
$115Kresearch payments (2019-2025)
3,321clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $44K
2020 $59K
2021 $206K
2022 $509K
2023 $159K
2024 $377K
2025 $137K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Obstetrics & Gynecology $971K
Gynecology $370K
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $53K
Gastroenterology (Internal Medicine) $22K
Pediatric Surgery $11K
Obstetrics $8,758

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Leslie Hansen-Lindner Charlotte, NC Obstetrics & Gynecology $323,438.02
David Levine Saint Louis, MO Gynecology $190,481.97
James Greenberg Boston, MA Obstetrics & Gynecology $87,239.72
Kelly Roy Phoenix, AZ Gynecology $60,666.97
Taraneh Shirazian New York, NY Obstetrics & Gynecology $56,485.54
Abraham Shashoua Chicago, IL Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $46,185.97
David Adler Loxahatchee, FL Obstetrics & Gynecology $34,263.76
David Schwartz Cincinnati, OH Obstetrics & Gynecology $31,683.20
Sunbal Javaid Cincinnati, OH Obstetrics & Gynecology $26,565.66
Charles Ascher-Walsh New York, NY Gynecology $26,101.68

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.